Examples of Ionotropic receptors in the following topics:
-
- Although both ionotropic and metabotropic receptors are activated by neurotransmitters, ionotropic receptors are channel-linked while metabotropic receptors initiate a cascade of molecules via G-proteins.
- Two types of membrane-bound receptors are activated with the binding of neurotransmitters: ligand-gated ion channels (LGICs) inotropic receptors and metabotropic G- protein coupled receptors.
- Examples of metabotropic receptors include glutamate receptors, muscarinic acetylcholine receptors, GABAB receptors, most serotonin receptors, and receptors for norepinephrine, epinephrine, histamine, dopamine, neuropeptides, and endocannabinoids.
- They have a much longer effect than ionotropic receptors, which open quickly but only remain open for a few milliseconds.
- While ionotropic channels have an effect only in the immediate region of the receptor, the effects of metabotropic receptors can be more widespread throughout the cell.
-
- A large subset function as neurotransmitter receptors—they occur at postsynaptic sites, and the chemical ligand that gates them is released by the presynaptic axon terminal.
- Ligand-gated ion channels (LGICs) are one type of ionotropic receptor or channel-linked receptor.
-
- Sensory receptors can be classified by the type of stimulus that generates a response in the receptor.
- Sensory receptors perform countless functions in our bodies.
- Cutaneous receptors are
sensory receptors found in the dermis or epidermis.[2]
- Encapsulated receptors consist of the remaining types of cutaneous
receptors.
- A tonic receptor is a sensory receptor that
adapts slowly to a stimulus, while a phasic receptor is a sensory receptor that
adapts rapidly to a stimulus.
-
- A receptor antagonist does not provoke a biological response upon receptor binding, but limits or dampens agonist-mediated responses.
- A receptor antagonist is a type of receptor ligand or drug that does not provoke a biological response itself upon binding to a receptor, but blocks or dampens agonist-mediated responses.
- Binding to the active site on the receptor regulates receptor activation directly.
- The current accepted definition of receptor antagonist is based on the receptor occupancy model.
- Irreversible antagonists covalently bind to the receptor target and, in general, cannot be removed; inactivating the receptor for the duration of the antagonist effects is determined by the rate of receptor turnover, the rate of synthesis of new receptors.
-
- Some sensory receptors can be classified by the physical location of the receptor.
- Remarkably, specialized receptors have evolved to transmit sensory inputs from each of these sensory systems.
- Receptors are sensitive to discrete stimuli and are often classified by both the systemic function and the location of the receptor.
- Sensory receptors are found throughout our bodies, and sensory receptors that share a common location often share a common function.
- For example, sensory receptors in the retina are almost entirely photoreceptors.
-
- There are two types of receptors: internal receptors and cell-surface receptors.
- Internal receptors can directly influence gene expression without having to pass the signal on to other receptors or messengers.
- There are three general categories of cell-surface receptors: ion channel-linked receptors, G-protein-linked receptors, and enzyme-linked receptors.
- Enzyme-linked receptors are cell-surface receptors with intracellular domains that are associated with an enzyme.
- An example of this type of enzyme-linked receptor is the tyrosine kinase receptor.
-
- Hormones target a limited number of cells (based on the presence of a specific receptor) as they circulate in the bloodstream.
- This androgen insensitivity occurs when the receptors on the target cells are unable to accept the hormone due to an impairment in receptor shape.
- Target cells are capable of responding to hormones because they display receptors to which the circulating hormone can bind.
- Finally, hormone-receptor affinity can be altered by expression of associated inhibitory or co-activating factors.
- In some instances alterations of receptor structure due to a genetic mutation can lead to a reduction in hormone-receptor affinity as in the case of androgen insensitivity.
-
- Adrenergic receptors are molecules that bind catecholamines.
- There are two main groups of adrenergic receptors, α and β, with several subtypes. α receptors have the subtypes α1 (a Gq coupled receptor) and α2 (a Gi coupled receptor).
- Phenylephrine is a selective agonist of the α receptor. β receptors have the subtypes β1, β2 and β3.
- α1-adrenergic receptors are members of the G protein-coupled receptor superfamily.
- This schematic shows the mechanism of adrenergic receptors.
-
- Hormones can alter cell activity by binding with a receptor.
- Receptors which can directly influence gene expression are termed nuclear receptors.
- Type I nuclear receptors are located in the cytosol.
- Type II receptors are retained in the nucleus .
- Most hormone receptors are G protein-coupled receptors.
-
- Ligand binding to cell-surface receptors activates the receptor's intracellular components setting off a signaling pathway or cascade.
- Cell-surface receptors, also known as transmembrane receptors, are membrane-anchored (integral) proteins that bind to external ligand molecules.
- There are three general categories of cell-surface receptors: ion channel-linked receptors, G-protein-linked receptors, and enzyme-linked receptors.
- All G-protein-linked receptors have seven transmembrane domains, but each receptor has its own specific extracellular domain and G-protein-binding site.
- Enzyme-linked receptors are cell-surface receptors with intracellular domains that are associated with an enzyme.